ACOG
Alpha Cognition Inc. Common Stock
Nasdaq · usd
Alpha Cognition Inc. Common Stock (ACOG) trades at $8.30 (-0.54%) as of 2:23:45 PM EDT on Oct 26, 2026, -2.07% over the past month. Market cap is $181.63M, with 2.8 days to cover in short interest.
Stock performance
How Alpha Cognition Inc. Common Stock (ACOG) stock has performed from one day to one year, with its 52-week range.
- 1D
- -0.54%
- 1W
- -2.41%
- 1M
- -2.07%
- YTD
- +27.62%
- 1Y
- +23.99%
- 52-wk range
- $4.50 – $10.14
Key statistics
Today's trading snapshot for ACOG: day range, open, previous close, volume and market cap.
- Day range
- $8.08 – $8.40
- Open
- $8.30
- Prev close
- $8.34
- Volume
- 39.48K
- Market cap
- $181.63M
- Shares out
- 21.78M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Alpha Cognition Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 11.90
- P/B
- 3.43
- P/FCF
- —
- ROE
- -44.3%
- ROA
- -36.3%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Alpha Cognition Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Annual meeting resultsJun 23, 2026
At the Meeting, the number of directors was set to six (6), all nominees for director were elected to office, and the ratification of the independent registered public accounting firm was approved.
- Director appointmentApr 20, 2026
On April 15, 2026, the Board appointed Bethany Sensenig as a director of the Company. Ms. Sensenig was most recently Chief Financial Officer and Head of Operations at Radius Health, Inc (May 2024 to April 2026), a commercial stage biopharmaceutical company, where she played a critical leadership role in the growth, financial performance, and sale of the company.
- Settlement agreementApr 14, 2026
On April 10, 2026, Alpha Cognition Inc. (the "Company") entered into a settlement agreement and mutual release (the "Early Settlement Agreement") with Galantos Pharma GmbH i.L. a company in liquidation...to extinguish certain future payment obligations arising under the Memogain Asset Purchase Agreement dated August 23, 2013...the Company agreed to make a one-time payment to the Galantos of EUR 5,214,220 in full satisfaction of remaining contingent obligations, including royalty and milestone-related payments under the Original Agreement.
- Shareholder meeting noticeMar 27, 2026
the board of directors of the Company (the "Board") has set a meeting date of June 16, 2026 for the Company's 2026 Annual General Meeting of Shareholders (the "Meeting"). The Board also set April 24, 2026 as the record date for shareholders entitled to notice of, and vote at, the Meeting.
- Director departureFeb 23, 2026
On February 18, 2026, Len Mertz, a member of the board of directors (the "Board") of Alpha Cognition Inc. (the "Company"), notified the Board that he does not intend to stand for re-election at the Company's 2026 annual meeting (the "2026 Annual Meeting"). Mr. Mertz will continue to serve on the Board through the 2026 Annual Meeting, at which time his current term will expire.
ACOG short interest
How heavily ACOG is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 2.8
- Short interest
- 323.41K
- Avg volume
- 115.85K
As of · reported to FINRA twice monthly.
ACOG news
The latest news and headlines about Alpha Cognition Inc. Common Stock (ACOG).
- Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?neutralZacks Investment Research· Oct 23, 2026
- Alpha Cognition (ACOG) Q1 2026 Earnings TranscriptpositiveThe Motley Fool· May 14, 2026
- OTC Markets Group Announces Quarterly Index Performance and RebalancingpositiveGlobeNewswire Inc.· Jan 22, 2025
Frequently asked questions
What is the Alpha Cognition Inc. Common Stock (ACOG) stock price today?
Alpha Cognition Inc. Common Stock (ACOG) is trading at $8.30 (-0.54% on the day) as of 2:23:45 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Alpha Cognition Inc. Common Stock?
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options.
What is the short interest in ACOG?
As of Sep 30, 2026, ACOG has 323.41K shares short and 2.8 days to cover.
What exchange is ACOG listed on?
Alpha Cognition Inc. Common Stock (ACOG) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.
Build with AI
Build an analysis of ACOG with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ACOG analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.